Isracann Biosciences Inc (ISCNF)
0.0001
0.00 (0.00%)
USD |
OTCM |
Mar 27, 16:00
Isracann Biosciences Revenue (TTM)
Revenue (TTM) Chart
Historical Revenue (TTM) Data
Date | Value |
---|---|
May 31, 2019 | -0.0132M |
February 28, 2019 | 1.618M |
November 30, 2018 | 1.579M |
August 31, 2018 | 1.283M |
May 31, 2018 | 0.9167M |
February 28, 2018 | 0.312M |
November 30, 2017 | 0.2813M |
August 31, 2017 | 0.2581M |
Date | Value |
---|---|
May 31, 2017 | 0.2427M |
February 28, 2017 | 0.2238M |
November 30, 2016 | 0.2029M |
August 31, 2016 | 0.1786M |
May 31, 2016 | 0.1409M |
February 29, 2016 | 0.1045M |
November 30, 2015 | 0.0841M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (TTM) Range, Past 5 Years
-0.0132M
Minimum
May 2019
-0.0132M
Maximum
May 2019
-0.0132M
Average
-0.0132M
Median
May 2019
Revenue (TTM) Benchmarks
Acasti Pharma Inc | -- |
Aurinia Pharmaceuticals Inc | 175.51M |
Edesa Biotech Inc | -- |
Lexaria Bioscience Corp | 0.276M |
Liminal Biosciences Inc (DELISTED) | 0.3635M |